Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group
Per Pfeiffer, Hafdan Sorbye, Camilla Qvortrup, Mia Karlberg, Christian Kersten, Kirsten Vistisen, Birgitta Lindh, Jon Kroll Bjerregaard, Bengt Glimelius
Dyk ned i forskningsemnerne om 'Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group'. Sammen danner de et unikt fingeraftryk.